Antibody responses to the repetitive Plasmodium falciparum antigen Pf332 in humans naturally primed to the parasite

Clinical and Experimental Immunology

Volumn 129, Issue 2, 2002, Pages 318-325

  Ahlborg, N ^a   Haddad, D ^a   Siddique, A B ^a   Roussilhon, C ^b,c   Rogier, C ^d   Trape, J F ^e   Troye Blomberg, M ^a   Berzins, K ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b INSTITUT PASTEUR DE DAKAR   (Senegal)

^c INSTITUT PASTEUR   (France)

^d SERVICE DE SANTÉ DES ARMÉES   (France)

^e INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

Antibody specificity; B cell epitope; Pf332; Plasmodium falciparum

Indexed keywords

IMMUNOGLOBULIN G; PEPTIDE; VACCINE;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; HUMAN; MALARIA; NONHUMAN; PARASITE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SEROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY SPECIFICITY; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; EPITOPES; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; SENEGAL;

EID: 0036380691     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01891.x     Document Type: Article

References (43)

1. Bouharoun-Tayoun H, Attanath P, Sabchareon A, Chongsuphajaisiddhi T, Druilhe P. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med 1990; 172:1633-41.
2. Cohen S, McGregor IA, Carrington S. Gamma-globulin and aquired immunity to human malaria. Nature 1961; 192:733-7.
3. Blackman MJ, Heidrich H-G, Doniachie S, McBride JS, Holder AA. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J Exp Med 1990; 172:379-82.
4. Ahlborg N, Iqbal J, Björk L, Ståhl S, Perlmann P, Berzins K. Plasmodium falciparum: differential parasite growth inhibition mediated by antibodies to the antigens Pf332 and Pf155/RESA. Exp Parasitol 1996; 82:155-63.
5. Bouharoun-Tayoun H, Druilhe P. Plasmodium falciparum malaria. Evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect Immun 1992; 60:1473-81.
6. Hinterberg K, Scherf A, Gysin J et al. Plasmodium falciparum. The Pf332 antigen is secreted from the parasite by a Brefeldin A dependent pathway and is translocated to the erythrocyte membrane via the Maurer's clefts. Exp Parasitol 1994; 79:279-91.
7. Mattei D, Scherf A. The Pf332 gene codes for a megadalton protein of Plasmodium falciparum asexual blood stages. Mem Inst Oswaldo Cruz 1992; 87:163-8.
8. Wiesner J, Mattei D, Scherf A, Lanzer M. Biology of giant proteins of Plasmodium: resolution on polyacrylamide-agarose composite gels. Parasitol Today 1998; 14:38-40.
9. Berzins K, Anders RF. The malaria antigens. In: Wahlgren M, Perlmann P, eds. Malaria molecular and clinical aspects. Chur, Switzerland: Harwood Academic Publishers, 1999:181-216.
10. Anders RF. Multiple cross-reactivities amongst antigens of Plasmodium falciparum impair the development of protective immunity against malaria. Parasite Immunol 1986; 8:529-39.
11. Schofield L, Uadia P. Lack of Ir gene control in the immune response to malaria. I. A thymus-independent antibody response to the repetitive surface protein of sporozoites. J Immunol 1990; 144:2781-8.
12. Berzins K, Perlmann H, Wåhlin B et al. Passive immunization of Aotus monkeys with human antibodies to the Plasmodium falciparum antigen Pf155/RESA. Infect Immun 1991; 59:1500-6.
13. Perraut R, Mercereau-Puijalon O, Mattei D et al. Induction of opsonizing antibodies after injection of recombinant Plasmodium falciparum vaccine candidate antigens in preimmune Saimiri sciureus monkeys. Infect Immun 1995; 63:554-62.
14. Gysin J, Gavoille S, Mattei D et al. In vitro phagocytosis inhibition assay for the screening of potential candidate antigens for sub-unit vaccines against the asexual blood stage of Plasmodium falciparum. J Immunol Meth 1993; 159:209-19.
15. Perraut R, Mercereau-Puijalon O, Mattei D et al. Immunogenicity and efficacy trials with Plasmodium falciparum recombinant antigens identified as targets of opsonizing antibodies in the naive squirrel monkey Saimiri sciureus. Am J Trop Med Hyg 1997; 56:343-50.
16. Smith DB, Johnson KS. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-tranferase. Gene 1988; 6:31-40.
17. Nilsson B, Moks T, Jansson B et al. A synthetic IgG-binding domain based on staphylococcal protein A. Protein Eng 1987; 1:107-13.
18. k-restricted T-cell epitopes in the highly repetitive Plasmodium falciparum antigen Pf332. Mol Immunol 1997; 34:379-89.
19. Sällberg M, Rudén U, Magnius LO, Norrby E, Wahren B. Rapid 'tea-bag' peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins. Immunol Lett 1991; 30:59-68.
20. Berzins K, Perlmann H, Wåhlin B et al. Antibodies to repeated amino acid sequences in Pf155, a merozoite associated antigen of Plasmodium falciparum. Mem Inst Oswaldo Cruz 1986; 81 (Suppl. 2):77-81.
21. Trager W, Jensen JB. Human malaria parasites in continuous culture. Science 1976; 193:673-5.
22. Troye-Blomberg M, Perlmann H, Patarroyo ME, Perlmann P. Regulation of the immune response in Plasmodium falciparum malaria. II. Antigen specific proliferative responses in vitro. Clin Exp Immunol 1983; 53:345-53.
23. Rogier C, Commenges D, Trape JF. Evidence for an age-dependent pyrogenic threshold of Plasmodium falciparum parasitemia in highly endemic populations. Am J Trop Med Hyg 1996; 54:613-9.
24. Perlmann H, Berzins K, Wahlgren M et al. Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early stages of Plasmodium falciparum. J Exp Med 1984; 159:1686-704.
25. McGuinness D, Bennett S, Riley E. Statistical analysis of highly skewed immune response data. J Immunol Meth 1997; 201:99-114.
26. Ahlborg N, Iqbal J, Hansson M et al. Immunogens containing sequences from antigen Pf332 induce Plasmodium falciparum-reactive antibodies which inhibit parasite growth but not cytoadherence. Parasite Immunol 1995; 17:341-52.
27. Udomsangpetch R, Carlsson J, Wåhlin B et al. Reactivity of the human monoclonal antibody 33G2 with repeated sequences of three distinct Plasmodium falciparum antigens. J Immunol 1989; 142:3620-6.
28. Geerlings HJ, Weijer WJ, Bloemhoff W, Welling GW, Welling-Wester S. The influence of pH and ionic strength on the coating of peptides of herpes simplex virus type 1 in an enzyme-linked immunosorbent assay. J Immunol Meth 1988; 106:239-44.
29. Udomsangpetch R, Aikawa M, Berzins K, Wahlgren M, Perlmann P. Cytoadherence of knobless Plasmodium falciparum infected erythrocytes and its inhibition by a human monoclonal antibody. Nature 1989; 338:763-5.
30. Perraut R, Mercereau-Puijalon O, Diouf B et al. Seasonal fluctuation of antibody levels to Plasmodium falciparum parasitized red blood cell-associated antigens in two Senegalese villages with different transmission conditions. Am J Trop Med Hyg 2000; 62:746-51.
31. Wahlgren M, Berzins K, Perlmann P, Persson M. Characterization of the humoral immune response in Plasmodium falciparum malaria. II. IgG subclass levels of anti-P. falciparum antibodies in different sera. Clin Exp Immunol 1983; 54:135-42.
32. Quakyi IA, Otoo LN, Pombo D et al. Differential non-responsiveness in humans of candidate Plasmodium falciparum vaccine antigens. Am J Trop Med Hyg 1989; 41:125-34.
33. Riley EM, Bennett S, Jepson A et al. Human antibody responses to Pfs230, a sexual stage-specific surface antigen of Plasmodium falciparum: non-responsiveness is a stable phenotype but does not appear to be genetically regulated. Parasite Immunol 1994; 16:55-62.
34. Taylor RR, Egan A, McGuinness D et al. Selective recognition of malaria antigens by human serum antibodies is not genetically determined but is reminiscent of clonal imprinting. Int Immunol 1996; 8:905-15.
35. Modiano D, Chiucchiuini A, Petrarca V et al. Humoral response to Plasmodium falciparum Pf155/ring-infected erythrocyte antigen and Pf332 in three sympatric ethnic groups of Burkina Faso. Am J Trop Med Hyg 1998; 58:220-4.
36. Kulane A, Siddique AB, Sarthou J-L et al. Human immune responses to the highly repetitive Plasmodium falciparum antigen Pf332. Am J Trop Med Hyg 1999; 61:141-8.
37. Trape J-F, Rogier C, Konate L et al. The Dielmo project. a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. Am J Trop Med Hyg 1994; 51:123-37.
38. Warsame M, Wernsdorfer WH, Perlmann H et al. A malariometric survey in a rural community in the Muheza District, Tanzania. age profiles in the development of humoral immune responses. Acta Trop 1997; 68:239-53.
39. Mattei D, Scherf A. Subtelomeric chromosome instability in Plasmodium falciparum: short telomere-like sequence motifs found frequently at healed chromosome breakpoints. Mutat Res 1994; 324:115-20.
40. Mercereau-Puijalon O, Jacquemot C, Sarthou JL. A study of the genomic diversity of Plasmodium falciparum in Senegal 1. Typing by Southern blot analysis. Acta Trop 1991; 49:281-92.
41. Haddad D, Snounou G, Mattei D et al. Limited genetic diversity of Plasmodium falciparum in field isolates from Honduras. Am J Trop Med Hyg 1999; 60:30-4.
42. Fandeur T, Vazeux G, Mercereau-Puijalon O. The virulent Saimiri-adapted Palo Alto strain of Plasmodium falciparum does not express the ring-infected erythrocyte surface antigen. Mol Biochem Parasitol 1993; 60:241-8.
43. Werner EBE, Taylor WR, Holder AA. A Plasmodium chabaudi protein contains a repetitive region with a predicted spectrin-like structure. Mol Biochem Parasitol 1998; 94:185-96.